1-11 of 11
Donald L. Durden
Close
Sort by
Journal Articles

The Novel CDK9/CDK4/6/PI3K Triple Inhibitor LCI139 for the Treatment of MYC -Driven Mantle Cell Lymphoma

Dhananjaya Pal, Page Mangum Arditti, Krishnaiah Maddeboina, Cody C. McHale, Hsih-Te Yang, Bharath Yada, Hailey Lynn Dryden, David M Foureau, Donald L. Durden
Journal: Blood
Blood (2023) 142 (Supplement 1): 4180.
https://doi.org/10.1182/blood-2023-190023
Published: 2023
Journal Articles

The Novel Multitarget Small-Molecule Inhibitor SRX3177 Overcomes Ibrutinib Resistance in Mantle Cell Lymphoma

Dhananjaya Pal, Cody C. McHale, Samon Benrashid, Poornima Gourabathini, Krishnaiah Maddeboina, Kendra R. Vann, Rajeswaran Mani, Tatiana Kutateladze, Peter Martin, Maurizio Di Liberto, Selina Chen-Kiang, Steven I. Park, Donald L. Durden
Journal: Blood
Blood (2021) 138 (Supplement 1): 2262.
https://doi.org/10.1182/blood-2021-154253
Published: 2021
Journal Articles

Aurora Kinase Inhibition Overcomes Primary Venetoclax Failure and Leads to Synthetic Lethality in BCL2-Positive Lymphomas Via Upregulation of P53/P21/BAX Axis

Rajeswaran Mani, Samon Benrashid, Sarah E Teague, Scott C Jaros, Hsih-Te Yang, Lawrence J Druhan, David M Foureau, Nury M Steuerwald, Nilanjan Ghosh, Edward A. Copelan, Donald L. Durden, Belinda Avalos, Steven I. Park
Journal: Blood
Blood (2021) 138 (Supplement 1): 682.
https://doi.org/10.1182/blood-2021-146064
Published: 2021
Journal Articles

Dual Targeting of PI3Kdelta and BRD4 Sensitizes Acute Lymphoblastic Leukemia to Chemotherapy

Hye Na Kim, Cydney Nichols, Enzi Ji Jiang, MD PhD, Nour Abdel-Azim, Ariana Coba, DOnald L. Durden, MD PhD, Yong-Mi Kim, MD MPH, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1420.
https://doi.org/10.1182/blood-2018-99-116310
Published: 2018
Journal Articles

Wolinella Asparaginase as an Immunologically Distinct, Efficacious, and Potentially Less Toxic Asparaginase for Use in Lymphoid Malignancies.

Tanya C. Watt, MD, Frank G. Keller, MD, Donald L. Durden, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 861.
https://doi.org/10.1182/blood.V110.11.861.861
Published: 2007
Journal Articles

A Vascular Targeted Pan PI-3 Kinase Inhibitor, SF1126 with Activity Against Multiple Myeloma In Vivo .

Pradip De, PhD, Qiong Peng, PhD, Nandini Dey, MD, Breanne McDermitt, MD, Xiaodong Peng, PhD, Joseph Garlich, PhD, Sagar Lonial, MD, Donald L. Durden, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 244.
https://doi.org/10.1182/blood.V108.11.244.244
Published: 2006
Journal Articles

SHP-1 regulates Fcγ receptor–mediated phagocytosis and the activation of RAC

Anita M. Kant, Pradip De, Xiaodong Peng, Taolin Yi, David J. Rawlings, Jong Suk Kim, Donald L. Durden
Journal: Blood
Blood (2002) 100 (5): 1852–1859.
https://doi.org/10.1182/blood.V100.5.1852.h81702001852_1852_1859
Published: 2002
Journal Articles

PTEN controls immunoreceptor (immunoreceptor tyrosine-based activation motif) signaling and the activation of Rac

Brief Report
Jong Suk Kim, Xiaodong Peng, Pradip K. De, Robert L. Geahlen, Donald L. Durden
Journal: Blood
Blood (2002) 99 (2): 694–697.
https://doi.org/10.1182/blood.V99.2.694
Published: 2002
Journal Articles

Role of Src in the Modulation of Multiple Adaptor Proteins in FcRI Oxidant Signaling

Rae-Kil Park, Kayvon D. Izadi, Yashwant M. Deo, Donald L. Durden
Journal: Blood
Blood (1999) 94 (6): 2112–2120.
https://doi.org/10.1182/blood.V94.6.2112
Published: 1999
Journal Articles

SLP-76-Cbl-Grb2-Shc Interactions in FcγRI Signaling

Julie Chu, Yenbou Liu, Gary A. Koretzky, Donald L. Durden
Journal: Blood
Blood (1998) 92 (5): 1697–1706.
https://doi.org/10.1182/blood.V92.5.1697
Published: 1998
Journal Articles

Differential Activation of the Tyrosine Kinases ZAP-70 and Syk After FcγRI Stimulation

Naomi Taylor, Thomas Jahn, Susan Smith, Thomas Lamkin, Lisa Uribe, Yenbou Liu, Donald L. Durden, Kenneth Weinberg
Journal: Blood
Blood (1997) 89 (2): 388–396.
https://doi.org/10.1182/blood.V89.2.388
Published: 1997